StockNews.AI
EMBC
StockNews.AI
208 days

embecta to Report Fiscal First Quarter 2025 Financial Results

1. Embecta is hosting a Q1 2025 financial results call on February 6. 2. The webcast will provide operational updates and a Q&A session. 3. Embecta has a legacy of 100 years in insulin delivery. 4. The company aims to improve diabetes care through innovation.

3m saved
Insight
Article

FAQ

Why Neutral?

The upcoming earnings call may not significantly influence EMBC's stock prices directly.

How important is it?

Earnings calls typically affect stock prices; however, no major news was announced.

Why Short Term?

Investors may react to the call's outcomes in the short term only.

Related Companies

EMBC
January 23, 2025 17:00 ET  | Source: Embecta Corp. PARSIPPANY, N.J., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal first quarter 2025 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Thursday, February 6, 2025. Those who would like to participate may access the live webcast here, or access the teleconference here. The live webcast can also be accessed via the company’s website at investors.embecta.com. A webcast replay of the call will be available beginning at 11:00 a.m. ET on February 6, 2025, via the embecta investor relations website and archived on the website for one year. About embecta embecta is a global diabetes care company that is leveraging its 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram. Contacts:  MediaChristian GlazarSr. Director, Corporate Communications908-821-6922Contact Media RelationsInvestors Pravesh KhandelwalVP, Head of Investor Relations551-264-6547Contact IR

Related News